Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix End of Shelf-life Potency vs M-M-R II in Toddlers
NCT01681992Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2012
- Primary completion
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 3 trial of measles, mumps and rubella vaccine (live) in measles, mumps, rubella, sponsored by GSK. Started Oct 2012; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT01681992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681992.